Funding for MS Clinical Trials
On Tuesday April 5, 2011, the Government of Manitoba made $5 million available to the Manitoba Health Research Council (MHRC) to fund clinical trials for treating Chronic cerebro-spinal venous insufficiency (CCSVI) in patients with Multiple Sclerosis. The funding builds on Saskatchewan’s $5 million for clinical trials and builds a complementary approach between the provinces to support coordinated multi-site trials that will strengthen the conclusions about the effectiveness of the procedure.
Saskatchewan was the first province to initiate clinical trials for the MS CCSVI procedure when it launched a call for proposals in December 2010. The Saskatchewan Health Research Foundation (SHRF) is managing the publicly funded health research process and will release the outcome of the process soon.
MHRC will issue a call for proposals following consultations with SHRF to ensure proposal criteria and review processes are complementary.
MHRC will provide the money in stages to a top-quality research team to be chosen in a competitive grant review process based on accepted standards of science, ethics and clinical care. The MHRC will manage the grant funds according to our well-established grants management processes.
To download a copy of the Tuesday April 5, 2011 press release, click here.
Watch the MS Initiative page in the Programs section of our web site for ongoing updates as this call for proposals and granting process moves forward. |